Shares of other companies:
May 1, 2024 Inflation Persistence: No Fed Rate Cuts in Sight
April 29, 2024 Tesla, Baidu Join Forces for Self-Driving Tech in China
April 27, 2024 Alphabet and Microsoft’s AI Investments Yield Strong Returns
Nvidia’s Stock Is Still A Bargain
May 2, 2024
Amazon Q1 Earnings: Strong Value Proposition
May 1, 2024
3M Stock: Dividend Likely Cut In Half
May 1, 2024
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
April 12, 2024 Improve Your Financial Status: A How-To Guide
Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
IMRN Stock News and Mentions of Immuron Limited Stocktwits
Updated: May 3, 2024 (09:13)
Sector: Healthcare
Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.
We meticulously analyze the sentiment trend in each article for the last 60 days where Immuron Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of Immuron Limited (IMRN).
You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the Immuron stocks.
Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles
News and Mentions of Immuron Limited (IMRN)
May 3, 2024 (10:00) / "Benzinga" (by Globe Newswire)
Immuron Director Resignation - Immuron ( NASDAQ:IMRN )
MELBOURNE, Australia, May 03, 2024 ( GLOBE NEWSWIRE ) -- Immuron Limited ( IMCIMRN, an Australian based and globally integrated biopharmaceutical company, advises that Stephen Anastasiou has resigned from his position as Non-Executive Director effective today to focus on his other business ...
In Article Trend: Neutral
May 3, 2024 (10:00) / "GlobeNewswire" (by Immuron Limited)
Immuron Director Resignation
MELBOURNE, Australia, May 03, 2024 ( GLOBE NEWSWIRE ) -- Immuron Limited ( ASX: IMC. NASDAQ: IMRN ) , an Australian based and globally integrated biopharmaceutical company, advises that Stephen Anastasiou has resigned from his position as Non-Executive Director effective today to focus on his ...
In Article Trend: Neutral
April 15, 2024 (10:00) / "Benzinga" (by Globe Newswire)
Immuron to host Live Virtual Event - Immuron ( NASDAQ:IMRN )
MELBOURNE, Australia, April 15, 2024 ( GLOBE NEWSWIRE ) -- Immuron Limited ( IMCIMRN, an Australian based and globally integrated biopharmaceutical company is pleased to advise our Chief Executive Officer, Steven Lydeamore together with our Chief Scientific Officer, Dr. Jerry Kanellos and ...
In Article Trend: Neutral
April 15, 2024 (10:00) / "GlobeNewswire" (by Immuron Limited)
Immuron to host Live Virtual Event
MELBOURNE, Australia, April 15, 2024 ( GLOBE NEWSWIRE ) -- Immuron Limited ( ASX: IMC. NASDAQ: IMRN ) , an Australian based and globally integrated biopharmaceutical company is pleased to advise our Chief Executive Officer, Steven Lydeamore together with our Chief Scientific Officer, Dr. Jerry ...
In Article Trend: Neutral
April 10, 2024 (18:07) / "Benzinga" (by Avi Kapoor)
Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session - Ascent Solar Technologies ( NASDAQ:ASTI )
Shares of Ascent Solar Technologies, Inc. ASTI fell sharply during Wednesday's session after the company announced pricing of a $6 million public offering of shares at $0.14 per share. Ascent Solar Technologies shares dipped 50% to $0.1374 on Wednesday. Here are some other stocks moving in ...
In Article Trend: Neutral
April 10, 2024 (12:12) / "Benzinga" (by Avi Kapoor)
Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket - Pricesmart ( NASDAQ:PSMT )
Shares of PriceSmart, Inc. PSMT rose sharply in today's pre-market trading as the company posted better-than-expected earnings for its second quarter. The company reported quarterly earnings of $1.31 per share, beating market estimates of $1.25 per share.
In Article Trend: Neutral
April 10, 2024 (10:00) / "GlobeNewswire" (by Immuron Limited)
March 11, 2024 (12:08) / "Benzinga" (by Avi Kapoor)
Why Fangdd Network Group Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket - Avenue Therapeutics ( NASDAQ:ATXI ) , Auddia ( NASDAQ:AUUD )
Shares of Fangdd Network Group Ltd. DUO rose sharply in today's pre-market trading after the company announced its 2024 strategic layout with plans to enter the real estate stock asset services sector. Fangdd Network Group shares jumped 78.3% to $1.08 in pre-market trading
In Article Trend: Neutral
March 8, 2024 (13:23) / "Benzinga" (by Avi Kapoor)
Why Porch Group Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket - Porch Group ( NASDAQ:PRCH )
Shares of Porch Group, Inc. PRCH rose sharply in pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued FY24 guidance. Porch Group posted GAAP loss of 3 cents per share, versus market estimates for a loss of 21 cents per share.
In Article Trend: Neutral
March 7, 2024 (11:00) / "GlobeNewswire" (by Immuron Limited)
Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US
Highlights: ...
In Article Trend: Neutral
March 7, 2024 (11:00) / "Benzinga" (by Globe Newswire)
Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US - Immuron ( NASDAQ:IMRN )
Immuron proceeding to Phase 3 registration strategy with the FDA Travelan® topline clinical trial results demonstrate protective efficacy with single daily dose
In Article Trend: Neutral
Related stocks from Healthcare sector
This website uses cookies to ensure you get the best experience on our website